World Rugby to undertake mouthguard study to probe head injuries

(Reuters) – World Rugby will undertake a study using mouthguards embedded with microchips to monitor impacts during games with the aim of improving the detection and prevention of head injuries, the sport’s global governing body said.

More than 700 community level players in New Zealand, from Under-13 level and upwards, will participate in the study, which starts this month and is being led by academics from University of Otago.

The mouthguards collect and transmit data on head impacts in real time during games.

“Player welfare continues to be top priority,” World Rugby Chief Medical Officer Eanna Falvey said. “By commissioning and partnering in research, we can make evidence-based decisions that will advance our understanding of injuries.

“We have been monitoring instrumented mouthguard technology for some time, and rapid advances in sensitivity make it possible to distinguish between head impact, jump or shouting.

“The scale of this study should not be underestimated.”

Clubs in England’s Premiership — Leicester, Gloucester and Harlequins — already use microchipped mouthguards to monitor the impact of collisions.

Other sports are conducting mouthguard trials, including rugby league side Salford, while Liverpool and Manchester City will also use chipped mouthguards in age-group and women’s teams next season.

World Rugby also said this week that it would evaluate the latest eye-tracking technology to assist with the identification and management of concussions in the sport.

Concussions and their long-term effects have been in the spotlight since former players filed a lawsuit against governing bodies World Rugby, England’s Rugby Football Union and the Welsh Rugby Union which alleged a failure to protect them from the risks.

READ  Pound jumps over $1.25 and bank shares soar on Brexit deal hopes – business live

Many former rugby players have been diagnosed with permanent brain damage, early onset dementia, depression or symptoms and signs of chronic traumatic encephalopathy, or CTE.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.